Ado-trastuzumab emtansine Intravenous and Brimonidine
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Brimonidine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine ophthalmic, Brimonidine (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Brimonidine and brinzolamide ophthalmic
- Ado-trastuzumab emtansine Intravenous-Brimonidine and Timolol
- Ado-trastuzumab emtansine Intravenous-Brimonidine and timolol ophthalmic
- Ado-trastuzumab emtansine Intravenous-Brimonidine ophthalmic
- Ado-trastuzumab emtansine Intravenous-Brimonidine Tartrate eent
- Ado-trastuzumab emtansine Intravenous-Brimonidine Tartrate topical
- Brimonidine-Adox Pak 2/100
- Brimonidine-Adoxa
- Brimonidine-Adoxa CK
- Brimonidine-Adoxa Pak
- Brimonidine-Adoxa Pak 1/100
- Brimonidine-Adoxa Pak 1/150